Display options
Cite
Batistatou A, Zolota V, Tzoracoleftherakis E, et al. Papillary serous adenocarcinoma of the endocervix: A rare neoplasm. Immunohistochemical profile. Int J Gynecol Cancer. 2000;10(4):336-339doi: 10.1046/j.1525-1438.2000.010004336.x.
Batistatou, A., Zolota, V., Tzoracoleftherakis, E., & Scopa, C. D. (2000). Papillary serous adenocarcinoma of the endocervix: A rare neoplasm. Immunohistochemical profile. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 10(4), 336-339. https://doi.org/10.1046/j.1525-1438.2000.010004336.x
Batistatou, A., et al. "Papillary serous adenocarcinoma of the endocervix: A rare neoplasm. Immunohistochemical profile." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 10,4 (2000): 336-339. doi: https://doi.org/10.1046/j.1525-1438.2000.010004336.x
Batistatou A, Zolota V, Tzoracoleftherakis E, Scopa CD. Papillary serous adenocarcinoma of the endocervix: A rare neoplasm. Immunohistochemical profile. Int J Gynecol Cancer. 2000 Jul;10(4):336-339. doi: 10.1046/j.1525-1438.2000.010004336.x. PMID: 11240696.
Copy Download .nbib Format: NLM
Share it on

Int J Gynecol Cancer. 2000 Jul;10(4):336-339. doi: 10.1046/j.1525-1438.2000.010004336.x.

Papillary serous adenocarcinoma of the endocervix: A rare neoplasm. Immunohistochemical profile.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

A. Batistatou, V. Zolota, E. Tzoracoleftherakis, C. D. Scopa

Affiliations

  1. Departments of Pathology and Surgery, University Hospital, University of Patras Medical School, Patras, Greece.

PMID: 11240696 DOI: 10.1046/j.1525-1438.2000.010004336.x

Abstract

Serous adenocarcinoma of the endocervix is a rare carcinoma similar to the serous carcinoma of the ovary and the endometrium. We report a case of a 63-year-old woman with papillary serous adenocarcinoma arising within the endocervix, describing the clinical presentation and the morphologic characteristics of this rare neoplasm. A detailed immunohistochemical analysis on the expression of low- and high-molecular weight cytokeratins (AE1 and AE3), EMA, CEA, vimentin, B72.3, nm23, estrogen and progesterone receptors, LeuM1 (CD15), p53, Ki-67 antigen, and PCNA by tumor cells has also been carried out, which to our knowledge has not been previously reported.

Publication Types